Grifols, S.A.(GRFS)Earnings, Financials & Key Ratios
GRFS•NASDAQ
11.3× P/E·Price updated Jun 19, 2026
AboutGrifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.Show more
- Revenue$7.23B+0.2%
- EBITDA$1.62B-0.6%
- Net Income$386M+146.1%
- EPS (Diluted)0.57+147.8%
- Gross Margin35.7%-7.9%
- EBITDA Margin22.41%-0.8%
- Operating Margin16.43%-0.6%
- Net Margin5.34%+145.6%
- ROE4.77%+144.8%
GRFS Key Insights
Grifols, S.A. (GRFS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 2.8%
- ✓Trading at only 0.6x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 2.4%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GRFS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GRFS Price & Volume
Grifols, S.A. (GRFS) stock price & volume — 10-year historical chart
Loading chart...
GRFS Growth Metrics
Grifols, S.A. (GRFS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.27%
5 Years6.24%
3 Years6.02%
TTM1.02%
Profit CAGR
10 Years-3.16%
5 Years-8.99%
3 Years27.79%
TTM112.86%
EPS CAGR
10 Years-3.09%
5 Years-4.83%
3 Years22.51%
TTM114.86%
Return on Capital
10 Years7.1%
5 Years5.06%
3 Years5.61%
Last Year6.42%
GRFS Recent Earnings
Grifols, S.A. (GRFS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.17+7.3%
$0.16
Rev
$2.0B-1.4%
$2.0B
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.29-0.3%
$0.29
Rev
$2.3B-0.2%
$2.3B
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.29-0.3%
$0.29
Rev
$2.3B-0.2%
$2.3B
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.22-9.6%
$0.24
Rev
$2.2B+1.5%
$2.2B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.17vs $0.16+7.3% | $2.0Bvs $2.0B-1.4% |
| Q1 2026 | Feb 26, 2026 | $0.29vs $0.29-0.3% | $2.3Bvs $2.3B-0.2% |
| Q1 2026 | Feb 25, 2026 | $0.29vs $0.29-0.3% | $2.3Bvs $2.3B-0.2% |
| Q4 2025 | Nov 4, 2025 | $0.22vs $0.24-9.6% | $2.2Bvs $2.2B+1.5% |
Based on last 12 quarters of dataView full earnings history →
GRFS Peer Comparison
Grifols, S.A. (GRFS) competitors in Vaccines and plasma-derived therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TAK | 48.84B | 15.63 | 39.28 | 4.28% | 4.25% | 2.62% | 0.63 | |
 CSL | 14.76B | 360.96 | 21.08 | 0.33% | 14.57% | 34.48% | 1.60 | |
 BHVN | 1.44B | 13.57 | -1.98 | -8.66% | 5.36 | |||
 OCSL | 1.02B | 11.59 | 29.72 | 60.93% | 17.43% | 3.45% | 1.01 | |
 BCRX | 1.89B | 8.99 | 7.43 | 94.1% | -51.71% | |||
 RARE | 2.7B | 27.44 | -4.71 | 20.13% | -91.03% | -6.08% | ||
 AKRO | 4.5B | 54.65 | -14.57 | -30.58% | 0.05 | |||
 ALNY | 37.1B | 278.09 | 119.35 | 65.19% | 13.46% | 98.29% | 1.62 |
Compare GRFS vs Peers
Grifols, S.A. (GRFS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GRFS Income Statement
Grifols, S.A. (GRFS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 4.32B | 4.49B | 5.1B | 5.34B | 4.93B | 6.06B | 6.59B | 7.21B | 7.23B | 7.45B |
Revenue Growth % | 6.62% | 3.91% | 13.64% | 4.73% | -7.62% | 22.92% | 8.71% | 9.41% | 0.2% | 1.02% |
Cost of Goods Sold | 2.17B | 2.44B | 2.76B | 3.08B | 2.97B | 3.85B | 4.11B | 4.42B | 4.65B | 4.64B |
COGS % of Revenue | 50.16% | 54.32% | 54.08% | 57.77% | 60.22% | 63.49% | 62.33% | 61.25% | 64.3% | - |
Gross Profit | 2.15B▲ 0% | 2.05B▼ 4.8% | 2.34B▲ 14.2% | 2.26B▼ 3.7% | 1.96B▼ 13.0% | 2.21B▲ 12.8% | 2.48B▲ 12.2% | 2.79B▲ 12.5% | 2.58B▼ 7.7% | 2.81B▲ 0% |
Gross Margin % | 49.84% | 45.68% | 45.92% | 42.23% | 39.78% | 36.51% | 37.67% | 38.75% | 35.7% | 37.68% |
Gross Profit Growth % | 12.54% | -4.76% | 14.23% | -3.68% | -12.97% | 12.8% | 12.19% | 12.53% | -7.68% | - |
Operating Expenses | 1.15B | 1.06B | 1.21B | 1.26B | 1.37B | 1.43B | 1.7B | 1.6B | 1.39B | 1.55B |
OpEx % of Revenue | 26.6% | 23.52% | 23.73% | 23.58% | 27.72% | 23.6% | 25.81% | 22.22% | 19.27% | - |
Selling, General & Admin | 860.35M | 814.77M | 942.82M | 985.62M | 1.06B | 1.11B | 1.27B | 1.14B | 1.02B | 1.11B |
SG&A % of Revenue | 19.92% | 18.16% | 18.49% | 18.46% | 21.52% | 18.27% | 19.2% | 15.86% | 14.13% | - |
Research & Development | 288.32M | 240.66M | 276.02M | 294.22M | 354.88M | 361.14M | 395.28M | 384.04M | 358.28M | 420.15M |
R&D % of Revenue | 6.68% | 5.36% | 5.41% | 5.51% | 7.19% | 5.96% | 6% | 5.32% | 4.96% | - |
Other Operating Expenses | 0 | 0 | -8.97M | -20.8M | -48.86M | -37.66M | 40.36M | 74.48M | 13.45M | 0 |
Operating Income | 1B▲ 0% | 994.12M▼ 0.9% | 1.13B▲ 13.8% | 996.13M▼ 12.0% | 595.06M▼ 40.3% | 782.44M▲ 31.5% | 782.32M▼ 0.0% | 1.19B▲ 52.4% | 1.19B▼ 0.4% | 1.26B▲ 0% |
Operating Margin % | 23.24% | 22.16% | 22.19% | 18.65% | 12.06% | 12.9% | 11.87% | 16.53% | 16.43% | 16.88% |
Operating Income Growth % | 6.81% | -0.92% | 13.81% | -11.95% | -40.26% | 31.49% | -0.02% | 52.37% | -0.4% | - |
EBITDA | 1.22B | 1.22B | 1.43B | 1.32B | 954.83M | 1.19B | 1.23B | 1.63B | 1.62B | 1.61B |
EBITDA Margin % | 28.23% | 27.25% | 28.12% | 24.68% | 19.36% | 19.68% | 18.64% | 22.6% | 22.41% | 21.6% |
EBITDA Growth % | 6.8% | 0.32% | 17.26% | -8.1% | -27.54% | 24.99% | 2.96% | 32.65% | -0.64% | -0.4% |
D&A (Non-Cash Add-back) | 215.49M | 228.61M | 302.45M | 321.53M | 359.77M | 410.98M | 446.42M | 437.9M | 432.24M | 351.03M |
EBIT | 945.25M | 1B | 1.14B | 1.1B | 584.27M | 782.56M | 723.08M | 1.05B | 1.19B | 1.21B |
Net Interest Income | -253.67M | -279.28M | -228.77M | -275.44M | -222.26M | -410.68M | -453.63M | -725.1M | -567.67M | -587.72M |
Interest Income | 9.68M | 13.99M | 114.2M | 9.14M | 11.55M | 33.86M | 62.43M | 48.05M | 32.66M | 9.55M |
Interest Expense | 249.53M | 274.16M | 324.38M | 284.58M | 233.81M | 444.54M | 516.06M | 773.15M | 600.33M | 597.28M |
Other Income/Expense | -307.62M | -268.28M | -314.26M | -117.5M | -244.61M | -444.42M | -575.3M | -748.02M | -596.49M | -644.91M |
Pretax Income | 695.72M▲ 0% | 725.84M▲ 4.3% | 817.1M▲ 12.6% | 878.63M▲ 7.5% | 350.45M▼ 60.1% | 338.01M▼ 3.5% | 207.02M▼ 38.8% | 444M▲ 114.5% | 590.73M▲ 33.0% | 612.54M▲ 0% |
Pretax Margin % | 16.11% | 16.18% | 16.03% | 16.45% | 7.1% | 5.57% | 3.14% | 6.16% | 8.17% | 8.22% |
Income Tax | 34.41M | 131.44M | 168.46M | 169.64M | 85.13M | 90.11M | 43.35M | 231.19M | 110.46M | 116.69M |
Effective Tax Rate % | 4.95% | 18.11% | 20.62% | 19.31% | 24.29% | 26.66% | 20.94% | 52.07% | 18.7% | 19.05% |
Net Income | 662.7M▲ 0% | 596.64M▼ 10.0% | 625.15M▲ 4.8% | 618.55M▼ 1.1% | 188.73M▼ 69.5% | 185.03M▼ 2.0% | 42.32M▼ 77.1% | 156.92M▲ 270.8% | 386.13M▲ 146.1% | 415.56M▲ 0% |
Net Margin % | 15.35% | 13.3% | 12.26% | 11.58% | 3.83% | 3.05% | 0.64% | 2.18% | 5.34% | 5.58% |
Net Income Growth % | 21.49% | -9.97% | 4.78% | -1.06% | -69.49% | -1.96% | -77.13% | 270.81% | 146.07% | 112.86% |
Net Income (Continuing) | 661.31M | 594.41M | 648.64M | 708.99M | 265.33M | 247.9M | 163.67M | 212.81M | 480.27M | 495.85M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 4.89M | 471.05M | 2.27B | 1.61B | 1.79B | 2.33B | 2.15B | 2.72B | 2.33B | 2.39B |
EPS (Diluted) | 0.97▲ 0% | 0.87▼ 10.3% | 0.94▲ 8.0% | 0.73▼ 22.3% | 0.27▼ 63.0% | 0.31▲ 14.8% | 0.09▼ 71.0% | 0.23▲ 155.6% | 0.57▲ 147.8% | 0.61▲ 0% |
EPS Growth % | 21.25% | -10.31% | 8.05% | -22.34% | -63.01% | 14.81% | -70.97% | 155.56% | 147.83% | 114.86% |
EPS (Basic) | 0.97 | 0.87 | 0.95 | 0.73 | 0.27 | 0.31 | 0.09 | 0.23 | 0.57 | - |
Diluted Shares Outstanding | 684.24M | 684.71M | 663.69M | 685.52M | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M | 680.58M |
Basic Shares Outstanding | 684.2M | 684.71M | 659.98M | 685.52M | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M | 680.58M |
Dividend Payout Ratio | 32.93% | 46.74% | 38.19% | 18.31% | 133.76% | 0.32% | - | 0.61% | 31.84% | - |
GRFS Balance Sheet
Grifols, S.A. (GRFS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2.95B | 3.48B | 6.02B | 3.16B | 5.51B | 4.69B | 6.13B | 5.73B | 5.07B | 5.26B |
Cash & Short-Term Investments | 886.52M | 1.03B | 2.76B | 590.51M | 2.69B | 580.24M | 646.04M | 1B | 824.65M | 702.73M |
Cash Only | 886.52M | 1.03B | 832.87M | 579.65M | 655.49M | 549.21M | 529.58M | 979.78M | 824.65M | 702.73M |
Short-Term Investments | 0 | 0 | 1.93B | 10.86M | 2.03B | 31.03M | 116.47M | 21.18M | 0 | 0 |
Accounts Receivable | 385.26M | 401.57M | 528.13M | 383.23M | 434.14M | 774.2M | 692.86M | 1.08B | 844.64M | 959M |
Days Sales Outstanding | 32.57 | 32.67 | 37.81 | 26.19 | 32.12 | 46.6 | 38.36 | 54.62 | 42.66 | 50.92 |
Inventory | 1.63B | 1.95B | 2.63B | 2B | 2.26B | 3.24B | 3.48B | 3.56B | 3.29B | 3.46B |
Days Inventory Outstanding | 274.55 | 291.94 | 348.07 | 236.91 | 277.62 | 306.77 | 309.38 | 294.13 | 258.77 | 264.65 |
Other Current Assets | 33.06M | 63.1M | 78.03M | 172.88M | 131.63M | 80.88M | 1.31B | 78.58M | 100.96M | 136.14M |
Total Non-Current Assets | 7.97B | 8.99B | 11.43B | 12.11B | 13.72B | 16.54B | 14.86B | 15.68B | 14.68B | 14.84B |
Property, Plant & Equipment | 1.76B | 1.95B | 3.21B | 3B | 3.34B | 4.28B | 4.19B | 4.31B | 4.05B | 3.17B |
Fixed Asset Turnover | 2.45x | 2.30x | 1.59x | 1.78x | 1.48x | 1.42x | 1.57x | 1.67x | 1.78x | 2.07x |
Goodwill | 4.59B | 5.21B | 6.18B | 5.33B | 6.23B | 7.01B | 6.8B | 7.4B | 6.83B | 10.64B |
Intangible Assets | 1.27B | 1.39B | 1.61B | 1.56B | 1B | 2.95B | 1.21B | 2.93B | 2.73B | 0 |
Long-Term Investments | 259.06M | 228.82M | 278.35M | 2.07B | 2.27B | 1.99B | 451.9M | 528.97M | 592.75M | 2.17B |
Other Non-Current Assets | 29.84M | 105.69M | 6.1M | 0 | 882.61M | 124.19M | 2.21B | 167.72M | 15.99M | 428.45M |
Total Assets | 10.92B▲ 0% | 12.48B▲ 14.3% | 17.45B▲ 39.8% | 15.27B▼ 12.4% | 19.23B▲ 25.9% | 21.23B▲ 10.4% | 20.99B▼ 1.1% | 21.41B▲ 2.0% | 19.75B▼ 7.7% | 20.1B▲ 0% |
Asset Turnover | 0.40x | 0.36x | 0.29x | 0.35x | 0.26x | 0.29x | 0.31x | 0.34x | 0.37x | 0.37x |
Asset Growth % | 7.8% | 14.26% | 39.83% | -12.45% | 25.92% | 10.38% | -1.12% | 1.97% | -7.73% | -25.06% |
Total Current Liabilities | 977.99M | 1.26B | 1.53B | 1.34B | 3.47B | 2.02B | 2.33B | 2.16B | 2.02B | 2.13B |
Accounts Payable | 423.1M | 561.88M | 653.16M | 601.62M | 628.99M | 787.96M | 822.95M | 852.3M | 840.64M | 0 |
Days Payables Outstanding | 71.3 | 84.15 | 86.46 | 71.18 | 77.29 | 74.7 | 73.11 | 70.42 | 66.03 | 33.8 |
Short-Term Debt | 129.12M | 7.08M | 358.69M | 276.93M | 2.35B | 578.92M | 916.51M | 523.13M | 385.84M | 589.61M |
Deferred Revenue (Current) | 14.23M | 15.53M | 24.1M | 23.98M | 0 | 37.83M | 0 | 70.86M | 76.97M | 76.97M |
Other Current Liabilities | 275.65M | 507.75M | 294.78M | 264.51M | 119.44M | 381.59M | 108.6M | 81.95M | 459.8M | 1.54B |
Current Ratio | 3.01x | 2.77x | 3.92x | 2.37x | 1.59x | 2.32x | 2.64x | 2.66x | 2.51x | 2.47x |
Quick Ratio | 1.35x | 1.22x | 2.21x | 0.87x | 0.94x | 0.72x | 1.14x | 1.01x | 0.88x | 0.85x |
Cash Conversion Cycle | 235.82 | 240.46 | 299.42 | 191.92 | 232.45 | 278.67 | 274.63 | 278.34 | 235.4 | 281.77 |
Total Non-Current Liabilities | 6.31B | 6.52B | 8.22B | 7.22B | 8.44B | 11.23B | 11.15B | 10.64B | 10.12B | 10.12B |
Long-Term Debt | 5.87B | 6.01B | 6.84B | 5.9B | 6.94B | 8.15B | 8.99B | 8.42B | 7.39B | 9.09B |
Capital Lease Obligations | 5.42M | 9.54M | 781.58M | 690.86M | 825.16M | 914.59M | 1B | 1.02B | 968.59M | 1.95B |
Deferred Tax Liabilities | 388.91M | 404.4M | 520.65M | 556.81M | 0 | 1.03B | 0 | 1.01B | 906.61M | 1.83B |
Other Non-Current Liabilities | 29.4M | 86.37M | 77.45M | 53.93M | 675.34M | 1.12B | 1.16B | 170.46M | 854.64M | 1.03B |
Total Liabilities | 7.29B | 7.78B | 9.75B | 8.55B | 11.92B | 13.25B | 13.48B | 12.8B | 12.13B | 12.24B |
Total Debt | 6.01B | 6.03B | 7.98B | 6.91B | 10.17B | 9.75B | 11.02B | 10.09B | 8.74B | 9.68B |
Net Debt | 5.12B | 5B | 7.14B | 6.33B | 9.51B | 9.2B | 10.49B | 9.11B | 7.92B | 8.98B |
Debt / Equity | 1.65x | 1.28x | 1.04x | 1.03x | 1.39x | 1.22x | 1.47x | 1.17x | 1.15x | 1.23x |
Debt / EBITDA | 4.93x | 4.93x | 5.56x | 5.25x | 10.65x | 8.17x | 8.97x | 6.19x | 5.40x | 6.02x |
Net Debt / EBITDA | 4.20x | 4.09x | 4.98x | 4.81x | 9.96x | 7.71x | 8.53x | 5.59x | 4.89x | 5.58x |
Interest Coverage | 3.79x | 3.65x | 3.52x | 3.87x | 2.50x | 1.76x | 1.40x | 1.35x | 1.98x | 2.02x |
Total Equity | 3.63B▲ 0% | 4.7B▲ 29.2% | 7.68B▲ 63.6% | 6.72B▼ 12.5% | 7.32B▲ 8.9% | 7.98B▲ 9.0% | 7.51B▼ 5.8% | 8.61B▲ 14.6% | 7.6B▼ 11.7% | 7.86B▲ 0% |
Equity Growth % | -2.52% | 29.24% | 63.62% | -12.55% | 8.88% | 9.01% | -5.8% | 14.55% | -11.7% | -30.69% |
Book Value per Share | 5.31 | 6.86 | 11.58 | 9.80 | 10.74 | 11.73 | 11.05 | 12.66 | 11.17 | 11.54 |
Total Shareholders' Equity | 3.63B | 4.23B | 5.41B | 5.11B | 5.52B | 5.65B | 5.37B | 5.88B | 5.27B | 5.46B |
Common Stock | 1.03B | 1.03B | 134.26M | 119.6M | 119.6M | 119.6M | 119.6M | 119.6M | 119.95M | 120.13M |
Retained Earnings | 539.71M | 459.89M | 0 | 618.55M | 248M | 0 | 79.36M | 156.92M | 0 | 0 |
Treasury Stock | -62.42M | -55.44M | -55.66M | -43.73M | -164.19M | -162.22M | -152.75M | -134.45M | -130.94M | -131.14M |
Accumulated OCI | 2.12B | 2.79B | 4.31B | 3.5B | 4.41B | 4.78B | 4.41B | 4.83B | 4.37B | 4.56B |
Minority Interest | 4.89M | 471.05M | 2.27B | 1.61B | 1.79B | 2.33B | 2.15B | 2.72B | 2.33B | 2.39B |
GRFS Cash Flow Statement
Grifols, S.A. (GRFS) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 841.75M | 737.43M | 568.93M | 1.11B | 596.98M | -10.87M | 218.69M | 902.17M | 1.01B | 1.01B |
Operating CF Margin % | 19.49% | 16.44% | 11.16% | 20.79% | 12.1% | -0.18% | 3.32% | 12.51% | 13.92% | - |
Operating CF Growth % | 52.14% | -12.39% | -22.85% | 95.16% | -46.23% | -101.82% | 2112.42% | 312.53% | 11.47% | -66.1% |
Net Income | 695.72M | 725.84M | 817.1M | 618.55M | 188.73M | 361.26M | 207.02M | 444M | 386.13M | 415.56M |
Depreciation & Amortization | 215.49M | 228.61M | 302.45M | 321.53M | 359.77M | 407.86M | 446.42M | 437.9M | 432.24M | 442.76M |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -3.67M | -104.38M | -69.09M | 61.66M | 229.84M | -170.77M | -71.91M | -2.1M | 211.32M | 234.85M |
Working Capital Changes | -65.8M | -112.64M | -481.54M | 108.6M | -181.35M | -609.22M | -362.84M | 22.38M | -24.01M | -82.05M |
Change in Receivables | 80.11M | -13.14M | -99.37M | -35.43M | -16.81M | -80.17M | -68.81M | -41.88M | -30.74M | -17.28M |
Change in Inventory | -165.51M | -231.67M | -323.75M | 164.63M | -157.47M | -600.25M | -411.44M | 25.82M | -93.17M | -173.73M |
Change in Payables | 22.29M | 135.26M | 0 | 0 | 0 | 80.21M | 0 | 0 | 90.29M | 88.19M |
Cash from Investing | -2.19B | -781.87M | -548.79M | -858.12M | -854.15M | -1.98B | -394.72M | 886.67M | -556.15M | -498.39M |
Capital Expenditures | -322.97M | -307.72M | -310.38M | -280.15M | -247.37M | -375.56M | -224.44M | -232.54M | -406.31M | -352.62M |
CapEx % of Revenue | 7.48% | 6.86% | 6.09% | 5.25% | 5.01% | 6.19% | 3.4% | 3.22% | 5.62% | 4.73% |
Acquisitions | -1.86B | -524.08M | -119.75M | -468.59M | -519.13M | -1.44B | -29.47M | -285.87M | -99.9M | -26.78M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 762K | 550K | -99.21M | -109.37M | -87.65M | 3.28M | -62.63M | 1.45B | 0 | -68.85M |
Cash from Financing | 1.43B | 152.5M | -332.36M | -354.4M | 2.3B | -173.49M | 171.49M | -1.36B | -508.12M | -527.14M |
Debt Issued (Net) | 1.81B | 37.42M | -73.78M | -243.37M | 2.75B | -104.29M | -116.39M | -111.49M | -182.5M | -808.01M |
Equity Issued (Net) | 0 | 0 | 0 | 0 | -125.7M | -3.46M | 0 | 0 | -123.91M | -127.71M |
Dividends Paid | -218.26M | -278.84M | -238.74M | -113.23M | -252.44M | -592K | 0 | -962K | -122.95M | -127.61M |
Share Repurchases | 0 | 0 | 0 | 0 | -125.7M | -3.46M | 0 | 0 | -123.91M | -124.38M |
Other Financing | -156.45M | 390.87M | -19.83M | 2.2M | -70.56M | -65.16M | 287.89M | -1.25B | -78.76M | 536.19M |
Net Change in Cash | -8.49M▲ 0% | 147.27M▲ 1835.0% | -291.81M▼ 298.1% | -162.34M▲ 44.4% | 2.1B▲ 1391.1% | -2.13B▼ 201.5% | -19.63M▲ 99.1% | 450.2M▲ 2393.4% | -38.85M▼ 108.6% | -67.27M▲ 0% |
Free Cash Flow | 518.77M▲ 0% | 429.71M▼ 17.2% | 156.63M▼ 63.5% | 830.18M▲ 430.0% | 349.6M▼ 57.9% | -386.43M▼ 210.5% | -91.63M▲ 76.3% | 530.8M▲ 679.3% | 751.14M▲ 41.5% | 744.54M▲ 0% |
FCF Margin % | 12.01% | 9.58% | 3.07% | 15.55% | 7.09% | -6.37% | -1.39% | 7.36% | 10.39% | 10% |
FCF Growth % | 99.08% | -17.17% | -63.55% | 430.03% | -57.89% | -210.53% | 76.29% | 679.29% | 41.51% | -20.67% |
FCF per Share | 0.76 | 0.63 | 0.24 | 1.21 | 0.51 | -0.57 | -0.13 | 0.78 | 1.10 | 1.09 |
FCF Conversion (FCF/Net Income) | 1.27x | 1.24x | 0.91x | 1.80x | 3.16x | -0.06x | 5.17x | 5.75x | 2.60x | 1.79x |
Interest Paid | 0 | 0 | 0 | 155.79M | 155.12M | 0 | 0 | 0 | 0 | 297.34M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GRFS Key Ratios
Grifols, S.A. (GRFS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 18% | 14.32% | 10.1% | 8.59% | 2.69% | 2.42% | 0.55% | 1.95% | 4.77% | 5.43% |
Return on Invested Capital (ROIC) | 9.13% | 8.08% | 6.92% | 5.36% | 2.99% | 3.45% | 3.34% | 5.01% | 5.36% | 5.81% |
Gross Margin | 49.84% | 45.68% | 45.92% | 42.23% | 39.78% | 36.51% | 37.67% | 38.75% | 35.7% | 37.68% |
Net Margin | 15.35% | 13.3% | 12.26% | 11.58% | 3.83% | 3.05% | 0.64% | 2.18% | 5.34% | 5.58% |
Debt / Equity | 1.65x | 1.28x | 1.04x | 1.03x | 1.39x | 1.22x | 1.47x | 1.17x | 1.15x | 1.23x |
Interest Coverage | 3.79x | 3.65x | 3.52x | 3.87x | 2.50x | 1.76x | 1.40x | 1.35x | 1.98x | 2.02x |
FCF Conversion | 1.27x | 1.24x | 0.91x | 1.80x | 3.16x | -0.06x | 5.17x | 5.75x | 2.60x | 1.79x |
Revenue Growth | 6.62% | 3.91% | 13.64% | 4.73% | -7.62% | 22.92% | 8.71% | 9.41% | 0.2% | 1.02% |
Related:GRFS Dividend History·GRFS Revenue History·GRFS Price History·GRFS P/E History·GRFS Financial Ratios·GRFS Institutional Holders
GRFS Frequently Asked Questions
Grifols, S.A. (GRFS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Grifols, S.A. (GRFS) reported $7.45B in revenue for fiscal year 2025. This represents a 1321% increase from $524.3M in 2005.
Grifols, S.A. (GRFS) grew revenue by 0.2% over the past year. Growth has been modest.
Yes, Grifols, S.A. (GRFS) is profitable, generating $415.6M in net income for fiscal year 2025 (5.3% net margin).
Dividend & Returns
Yes, Grifols, S.A. (GRFS) pays a dividend with a yield of 2.81%. This makes it attractive for income-focused investors.
Grifols, S.A. (GRFS) has a return on equity (ROE) of 4.8%. This is below average, suggesting room for improvement.
Grifols, S.A. (GRFS) generated $744.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.